VANCOUVER, British Columbia and LONDON, April 10, 2018 -- PAI Health (formerly Mio Global), a health technology company with proprietary science-based algorithms that prescribe exercise for optimal health, has entered into a collaboration with reinsurer Gen Re.
PAI (Personal Activity Intelligence) is a motivational heart-rate based activity metric proven to reduce cardiovascular disease and lifestyle risk. PAI technology offers insurers advanced behavioural insights and the measurement of individual and population rising risk and health trends.
PAI will work with Gen Re to develop insurance solutions for life and health clients in the global market that drive customer engagement and reduce risk.
“It is significant to be working with Gen Re, a global leader in the insurance industry,” said Peter Taylor, CEO of PAI Health. “Our combined expertise is a powerful collaboration to realize the full potential of PAI, improving consumers’ health and reducing healthcare and insurance costs on a global scale.”
Ross Campbell, Chief Underwriter, Gen Re International Life/Health Research and Development, comments “Collaborations offer a way for insurers to develop digital solutions that will provide policyholders with added value. We see potential for PAI in risk selection and promoting improved health among insurance customers. Working with PAI underlines Gen Re’s commitment to innovation.”
About PAI Health
Personal Activity Intelligence (PAI) is the first scientifically validated metric that provides personalized guidance on how much exercise is needed for optimal health. PAI Health is the new company formerly known as Mio Global, a successful pioneer in heart rate technology and wearables. PAI helps insurers to better manage risk and reduce costs through rising risk indicators of member health. To learn more visit: www.PAIhealth.com
About Gen Re
Gen Re is one of the leading reinsurers in the world, with a strong focus on health and life insurance. With $13 billion in capital and approx. $5.6 billion in premiums, it is one of the leading reinsurers in the world with a global network of offices in key reinsurance markets. To learn more visit: www.genre.com
Media Contacts:
Olivia Catuara
Uproar PR for PAI Health
[email protected]
312-878-4575 x246
Ross Campbell
Chief Underwriter
Life/Health Research & Development
Gen Re, UK
[email protected]


World game at war: why some European nations have threatened a World Cup boycott
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Capital One Says AML Review Led to Closure of Trump Organization Accounts
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Telegram Restored on Apple App Store After Temporary Removal
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Same sparkle, different story: how lab-grown diamonds are transforming the market
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 



